Literature DB >> 1714830

Parathyroid hormone and calcium: interactions in the control of renin secretion in the isolated, nonfiltering rat kidney.

J J Helwig1, M J Musso, C Judes, G A Nickols.   

Abstract

The present study was designed to characterize the interaction of calcium and PTH in the control of renin release in isolated rat kidneys perfused in a closed circuit at constant flow. Kidneys were rendered nonfiltering using low perfusion pressures (70 mm Hg) and a hyperoncotic perfusate (100 g/liter BSA). Under these conditions, differences in perfusion pressure were less than 9 mm Hg between control and PTH-treated kidneys over the 50 min of perfusion. In the absence of PTH, renin release was inversely correlated with ionized calcium (Ca2+) concentration, with the highest release of renin noted with 1 mM EGTA and no added calcium. Also, verapamil treatment markedly elevated renin release, even in the presence of 2 mM Ca2+. In contrast, renin secretion was strongly depressed by 20 nM BAY-K8644 in the perfusate. In medium containing normal calcium concentrations (1 mM Ca2+), rat PTH(1-34) induced a 2-fold greater renin accumulation than in the control, non-PTH-treated kidneys. Isoproterenol induced a 5-fold stimulation under the same conditions. In the 0 Ca2+/1 mM EGTA perfusion, PTH did not elevate renin secretion. Renin release in response to PTH in 2 mM Ca2+ was similar to that observed in the 1 mM Ca2+ perfusion. PTH also reversed the effects of BAY-K8644 to suppress renin release. In verapamil-treated kidneys, PTH failed to stimulate renin release. These results indicate that PTH stimulates renin release by a process independent of the baroreceptors and macula densa. The Ca2+ modulation of PTH-induced renin release is consistent with the reported ability of PTH to block calcium channels and relax vascular smooth muscle.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1714830     DOI: 10.1210/endo-129-3-1233

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  8 in total

Review 1.  The renin-angiotensin-aldosterone system and calcium-regulatory hormones.

Authors:  A Vaidya; J M Brown; J S Williams
Journal:  J Hum Hypertens       Date:  2015-01-29       Impact factor: 3.012

2.  Parathyroid hormone stimulates juxtaglomerular cell cAMP accumulation without stimulating renin release.

Authors:  Douglas K Atchison; Pamela Harding; M Cecilia Ortiz-Capisano; Edward L Peterson; William H Beierwaltes
Journal:  Am J Physiol Renal Physiol       Date:  2012-08-15

3.  Effect of intrarenally infused parathyroid hormone-related protein on renal blood flow and glomerular filtration rate in the anaesthetized rat.

Authors:  T Massfelder; N Parekh; K Endlich; C Saussine; M Steinhausen; J J Helwig
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

4.  Relationship between parathyroid hormone and renin-angiotensin-aldosterone system in hemodialysis patients with secondary hyperparathyroidism.

Authors:  Keiji Kono; Hideki Fujii; Kentaro Watanabe; Shunsuke Goto; Shinichi Nishi
Journal:  J Bone Miner Metab       Date:  2020-09-12       Impact factor: 2.626

5.  Vascular effects of parathyroid hormone and parathyroid hormone-related protein in the split hydronephrotic rat kidney.

Authors:  K Endlich; T Massfelder; J J Helwig; M Steinhausen
Journal:  J Physiol       Date:  1995-03-01       Impact factor: 5.182

Review 6.  Interactions between adrenal-regulatory and calcium-regulatory hormones in human health.

Authors:  Jenifer M Brown; Anand Vaidya
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2014-06       Impact factor: 3.243

7.  Parathyroid Hormone's Acute Effect on Vasodilatory Function.

Authors:  P Farahnak; L Lind; K Mattala; I-L Nilsson
Journal:  Clin Med Insights Endocrinol Diabetes       Date:  2010-04-26

Review 8.  The Interplay Between the Renin-Angiotensin-Aldosterone System and Parathyroid Hormone.

Authors:  Ming-Hui Zheng; Fu-Xing-Zi Li; Feng Xu; Xiao Lin; Yi Wang; Qiu-Shuang Xu; Bei Guo; Ling-Qing Yuan
Journal:  Front Endocrinol (Lausanne)       Date:  2020-08-20       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.